WP
ALNY icon

Westmount Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Westmount Partners’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Hold
1,000
– – 0.07% 212
2026
Q1 		$331K Hold
1,000
– – 0.08% 194
2025
Q4 		$398K Hold
1,000
– – 0.1% 159
2025
Q3 		$461K Hold
1,000
– – 0.12% 143
2025
Q2 		$326K Hold
1,000
– – 0.09% 180
2025
Q1 		$270K Hold
1,000
– – 0.08% 196
2024
Q4 		$235K Hold
1,000
– – 0.07% 192
2024
Q3 		$275K Sell
1,000
-5
-0.5% -$1.3K 0.08% 175
2024
Q2 		$245K Buy
+1,005
New +$159K 0.08% 180
2023
Q2 		– Sell
-1,000
Closed -$200K – 189
2023
Q1 		$200K Hold
1,000
– – 0.09% 172
2022
Q4 		$238K Buy
+1,000
New +$213K 0.12% 152

Other funds holding ALNY

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PSC
Portman Square Capital London, United Kingdom $2.11B AUM 19.71% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return